Trial Profile
Phase I Safety and Pharmacokinetic Study of ARRY-520 in Solid Tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Filanesib (Primary) ; Filgrastim
- Indications Solid tumours
- Focus Adverse reactions
- 05 Apr 2011 Status changed from active, no longer recruiting to completed.
- 05 Apr 2011 Planned end date changed from 1 Sep 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov.
- 18 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.